Search

Your search keyword '"Benkeser, David"' showing total 433 results

Search Constraints

Start Over You searched for: Author "Benkeser, David" Remove constraint Author: "Benkeser, David"
433 results on '"Benkeser, David"'

Search Results

2. Comparing HIV Vaccine Immunogenicity across Trials with Different Populations and Study Designs

3. A Density Ratio Super Learner

4. Fair Risk Minimization under Causal Path-Specific Effect Constraints

5. Monte Carlo Integration in Simple and Complex Simulation Designs

6. Nonparametric Motion Control in Functional Connectivity Studies in Children with Autism Spectrum Disorder

7. Technology-Based Interventions, with a Stepped Care Approach, for Reducing Sexual Risk Behaviors and Increasing PrEP Initiation Among Transgender and Gender Expansive Youth and Young Adults

8. Prepared, Protected, EmPowered (P3): Primary Results of a Randomized Controlled Trial Using a Social Networking, Gamification, and Coaching App to Promote Pre-exposure Prophylaxis (PrEP) Adherence for Sexual and Gender Minority (SGM) Youth Living in the United States

9. Technology-Based Stepped Care to Stem Transgender Adolescent Risk Transmission: Protocol for a Randomized Controlled Trial (TechStep)

10. Statistical learning for constrained functional parameters in infinite-dimensional models with applications in fair machine learning

11. Targeted Machine Learning for Average Causal Effect Estimation Using the Front-Door Functional

12. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

13. Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

15. Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

17. A Huber loss-based super learner with applications to healthcare expenditures

18. Efficient estimation of modified treatment policy effects based on the generalized propensity score

19. Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

20. Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.

22. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

23. Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial

24. Inference for natural mediation effects under case-cohort sampling with applications in identifying COVID-19 vaccine correlates of protection

25. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

26. Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials

27. Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

28. Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

29. Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

31. Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

32. Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya.

33. Nonparametric inference for interventional effects with multiple mediators

34. Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study

37. Efficient Estimation of Pathwise Differentiable Target Parameters with the Undersmoothed Highly Adaptive Lasso

38. Design and analysis considerations for a sequentially randomized HIV prevention trial

39. Improved Small-Sample Estimation of Nonlinear Cross-Validated Prediction Metrics

40. A machine learning-based approach for estimating and testing associations with multivariate outcomes.

42. A nonparametric super-efficient estimator of the average treatment effect

43. Robust inference on the average treatment effect using the outcome highly adaptive lasso

44. A machine learning-based approach for estimating and testing associations with multivariate outcomes

46. Don't Let Your Analysis Go to Seed: On the Impact of Random Seed on Machine Learning-based Causal Inference.

47. Comparing methods to address bias in observational data: statin use and cardiovascular events in a US cohort

50. Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020

Catalog

Books, media, physical & digital resources